Explore evidence

11.8 %11.8% of the 400 respondents tested positive for HIV.

NigeriaVIH/sidapublished 2023Journal of preventive medicine and hygienePubMeddocument of 9 observations

OSSN frequently showed an association with HIV infection at a tertiary referral centre in North West Nigeria.

Nigeriaocular surface squamous neoplasia (OSSN) · VIH/sidapublished 2022International ophthalmologyPubMeddocument of 5 observations

53 %In Nigeria, 53% of people living with HIV utilize HIV care and services.

NigeriaVIH/sidapublished 2020BMC health services researchPubMeddocument of 2 observations

5 %The prevalence of prolonged PR interval was 5% in HIV-positive children.

NigeriaVIH/sidapublished 2020The Nigerian postgraduate medical journalPubMeddocument of 9 observations

326 casesOf 3229 study participants, 326 were HIV infected as confirmed by Western Blot or RNA.

NigeriaVIH/sidaobserved 2009-12published 2016PloS onePubMeddocument of 14 observations

67.9 %Of the 2,739 PLHIV 15 years and above identified in NAIIS, 1,342 (67.9%) were linked to care.

NigeriaVIH/sidaobserved 2018published 2021PloS onePubMeddocument of 13 observations

69.5 %Among HIV-infected women attending a tertiary health facility in Kano, Nigeria, 69.5% were aware of their transmission risk during pregnancy.

NigeriaVIH/sidapublished 2019International journal of health policy and managementPubMeddocument of 10 observations

19 %Among adults aged 25–49 years, 19% had tested for HIV in the last 12 months preceding the 2016/2017 Multiple Indicator Cluster Survey in Nigeria.

NigeriaVIH/sidaobserved 2016/2017published 2020AIDS carePubMeddocument of 5 observations

34.5 %The prevalence of abnormal ECG findings in HIV-positive children was 34.5%.

NigeriaVIH/sidapublished 2020The Nigerian postgraduate medical journalPubMeddocument of 9 observations

4.8 %HIV seronegative women uninfected with HSV-2 had a cervical lesion prevalence of 4.8%.

NigeriaCervical Lesions · Herpes Simplex Virus Type-2 · VIH/sidapublished 2022Current HIV researchPubMeddocument of 4 observations

10.4 %La fréquence de la neuropathie chez les personnes vivant avec le VIH au Nigeria était de 10,4 % en 2009.

NigeriaVIH/sidaobserved 2009HAL · Unilimdocument of 747 observations

11.4 %At first viral load for 402,668 patients during 2016–21, virological non-suppression occurred in 46,051 (11.4%) individuals.

NigeriaVIH/sidaobserved 2016–21published 2022The Lancet. Global healthPubMeddocument of 5 observations

24.9 %Of the 8,329 eligible women in the 2018 Nigerian National Nutrition and Health Survey, 1,493 (24.9%) missed HIV pre-test counselling.

NigeriaVIH/sidaobserved 2018published 2022African journal of reproductive healthPubMeddocument of 5 observations

8.48 daysThe mean duration of hospitalization for HIV/AIDS admissions was 8.48 ± 7.08 days.

NigeriaVIH/sidapublished 2023West African journal of medicinePubMeddocument of 11 observations

8.82 µmol/lThe mean plasma glutathione level was 8.82 ± 2.39 µmol/l in HIV infected children.

NigeriaVIH/sidapublished 2021West African journal of medicinePubMeddocument of 4 observations

78.5 %78.5% of the participants experienced psychological challenges in accessing care during the COVID-19-induced lockdown.

NigeriaVIH/sidapublished 2022Nigerian journal of clinical practicePubMeddocument of 9 observations

3.66 hazard_ratioPatients with advanced disease (Stage IV) had a significantly higher risk of being lost to follow-up (hazard ratio 3.66).

NigeriaVIH/sidapublished 2022Journal of the International Association of Providers of AIDS CarePubMeddocument of 4 observations

87.5 %The self-reported ART adherence level was 87.5% in the south-west of Nigeria.

NigeriaVIH/sidapublished 2022African journal of AIDS research : AJARPubMeddocument of 4 observations

1,000 NGNThe median maximum amount people living with HIV (PLHIV) on antiretroviral therapy (ART) were willing to pay for clinical consultation was NGN1,000 (USD $2.78), with an interquartile range of NGN500–NGN2,000.

NigeriaVIH/sidaobserved July and August 2019published 2023PloS onePubMeddocument of 9 observations

Baseline LSM and median LSM decline were significantly higher in HIV/HBV- versus HIV-infected patients.

NigeriaHIV/HBV · VIH/sidapublished 2019The Journal of antimicrobial chemotherapyPubMeddocument of 8 observations

64.1 %The seroprevalence of cytomegalovirus (CMV) IgM antibodies among HIV-positive individuals attending the Ahmadu Bello University Teaching Hospital in Nigeria was 64.1%.

Nigeriacytomegalovirus (CMV) · VIH/sidapublished 2025Journal of infection in developing countriesPubMeddocument of 2 observations

3,796 sexual_contactsA total of 3,796 sexual contacts were elicited.

NigeriaVIH/sidaobserved Between March 2021 and April 2022published 2024Global health, science and practicePubMeddocument of 8 observations

13,000 casesHIV incidence in Akwa Ibom state, Nigeria, translated to 13,000 new cases of HIV infections annually in 2017.

NigeriaVIH/sidaobserved 2017published 2021Journal of the International AIDS SocietyPubMeddocument of 9 observations

45.9 %45.9% of HIV/AIDS admissions improved and were discharged home.

NigeriaVIH/sidapublished 2023West African journal of medicinePubMeddocument of 11 observations

12.34 aORClients receiving treatment at tertiary level facilities had an adjusted odds ratio of 12.34 for interruption of antiretroviral therapy.

NigeriaVIH/sidapublished 2021BMC public healthPubMeddocument of 12 observations